Indian Pharma - Live Stock Quotes, Stock Price Update and Analysis from Equitymaster.com
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian Pharma Stocks 

Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.

» Result Scoreboard | Best Performing Stocks | Refresh
SCRIP BSE PRICE (Rs) NSE PRICE (Rs) CHART MORE INFO
AARTI DRUGS 564.40 1.71% 564.75 1.26%
 More Info 
AJANTA PHARMA 1,025.75 1.09% 1,025.65 0.92%
 More Info 
ALEMBIC PHARMA 524.40 -1.04% 525.10 -0.43%
 More Info 
BIOCON 519.60 0.14% 518.35 -0.10%
 More Info 
CADILA HEALTHCARE 251.10 2.68% 250.35 2.29%
 More Info 
CIPLA 554.05 -0.84% 553.00 -1.14%
 More Info 
DIVIS LABORATORIES 1,678.85 -0.92% 1,680.20 -0.96%
 More Info 
GLENMARK PHARMA 569.60 -0.95% 570.05 -0.94%
 More Info 
INDOCO REMEDIES 182.80 -0.68% 184.95 1.09%
 More Info 
IPCA LABS 921.50 1.38% 924.45 0.55%
 More Info 
J.B.CHEMICALS 363.85 5.23% 364.90 5.69%
 More Info 
LUPIN 756.35 1.18% 757.20 1.31%
 More Info 
NATCO PHARMA 522.95 0.27% 520.50 -0.12%
 More Info 
NIFTY 50 Not Listed 11,737.90 0.25%
 More Info 
ORCHID PHARMA LTD 5.03 3.93% 18.90 -2.83%
 More Info 
PANACEA BIOTECH 196.20 1.79% 198.15 1.93%
 More Info 
PIRAMAL ENTERPRISES 2,186.15 -1.88% 2,184.70 -1.96%
 More Info 
S&P BSE SENSEX 39,110.21 0.36% Not Listed
 More Info 
STRIDES PHARMA SCIENCE 414.30 0.74% 414.25 0.61%
 More Info 
SUN PHARMA 420.65 2.92% 421.20 3.02%
 More Info 
TORRENT PHARMA 1,559.20 -2.61% 1,559.50 -2.62%
 More Info 
WOCKHARDT 394.15 2.83% 394.30 2.74%
 More Info 

BSE prices: May 22, 2019  (Close)    NSE prices: May 22, 2019  (Close)

Indian Pharma Stocks Update

The NIFTY PHARMA Index was at 8,530.2 (up 0.5%). The index is down 17.2% over the last 30 days. And over the last 1 year, it has lost 9.2%.

Within the Indian Pharma sector, the top gainers were J.B.CHEMICALS (up 5.2%) and ORCHID PHARMA LTD (up 3.9%). On the other hand, TORRENT PHARMA (down 2.6%) and PIRAMAL ENTERPRISES (down 1.9%) were among the top losers.

Meanwhile, the benchmark NIFTY 50 was at 11,737.9 (up 0.3%).




Today's Market

Lok Sabha Election Results 2019, Jet Airways Saga, and Top Cues in Focus Today(Pre-Open)

Indian share markets ended their day on a positive note yesterday ahead of counting of Lok Sabha Election 2019 to be done today.

Related Views on News

TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7% (Quarterly Result Update)

May 22, 2019 | Updated on May 22, 2019

For the quarter ended March 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 166.7% YoY). Sales on the other hand came in at Rs 19 bn (up 7.8% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


May 22, 2019 (Close)

COMPARE COMPANY

MARKET STATS